Educational only — not medical advice

Flatland Health does not prescribe, dispense, or sell peptides. We are not a clinic, pharmacy, or store. This article is consumer education based on public Health Canada information. Always consult a licensed Canadian practitioner.

The short version

Most injectable "wellness" peptides marketed online are unauthorized in Canada. Vials of BPC-157, TB-500 / thymosin beta-4, ipamorelin, CJC-1295, sermorelin, GHK-Cu, and similar products sold for body composition, "healing," or anti-aging generally do not have a Health Canada Notice of Compliance for those uses.

Authorized peptide drugs do exist as a regulated class — GLP-1 medicines like semaglutide and tirzepatide are peptides, and other peptide drugs have been authorized for specific medical indications over the years. Availability changes. Always verify a product's current Canadian status in the Health Canada Drug Product Database (DPD) rather than trusting a clinic pitch or an old blog post.

Health Canada advisory (April 2026)

Health Canada has warned Canadians to think twice before injecting peptides bought online. Unauthorized products can seriously harm you. Critically, a "research use only" label does not make those sales legal in Canada. Read the Health Canada advisory in full.

Why "research-use-only" is a legal fiction (in Canada)

You'll see US-based online shops selling vials labeled "for research purposes only, not for human consumption." That disclaimer doesn't make the vial safer or legal to inject. In Canada:

  • Compounds sold that way are not authorized as drugs by Health Canada, which means no one has verified their identity, purity, or dosage.
  • Importing an unauthorized drug for personal injection can be a customs offence.
  • If something goes wrong, no Canadian regulatory framework protects you and no insurer will cover the outcome.

We wrote a longer explainer — including the cases Health Canada has publicly flagged — at The Truth About "Research-Use-Only" Peptides in Canada.

About tesamorelin / Egrifta — please read carefully

Tesamorelin (brand names historically associated with Egrifta / Egrifta SV) is a GHRH analog that was studied and labelled for a narrow indication: reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. It is not a general weight-loss or "wellness" peptide.

Important availability caveat: Canadian Drug Identification Numbers (DINs) for Egrifta products have been cancelled / sale discontinued in Canada according to public database history, and Egrifta SV is primarily a US-marketed product. Flatland Health does not claim Egrifta is currently a marketed commercial option Canadian patients can easily obtain. Before anyone cites it as "available in Canada," verify a live DIN and marketed status in the Drug Product Database and speak with a licensed specialist.

If a wellness clinic pitches tesamorelin (or any GHRH analog) for anti-aging or body composition, treat that as a yellow flag: ask for the Canadian authorization pathway, the compounding pharmacy (if any), and the evidence for the claim.

What about peptides sold in Canadian "wellness clinics"?

Some clinics advertise compounded peptides. The picture is nuanced — and easy to oversell:

  • Compounding vs. commercial drugs: Canadian pharmacists can, under provincial pharmacy-college rules, compound preparations for individual patients. That is not the same as importing a research-chemical vial.
  • Off-label prescribing: A licensed Canadian physician may prescribe an authorized drug off-label when clinically appropriate. That is different from prescribing a substance that has never been authorized in Canada.
  • Ask three questions: (1) Is this specific peptide authorized by Health Canada — and can you show a live DPD entry / DIN? (2) Where is the vial compounded, and by which licensed Canadian pharmacy? (3) What Canadian evidence supports the specific claim?

Our editorial position

This page exists to educate and to redirect away from the gray market. When Health Canada–authorized options apply to your situation, see a licensed Canadian practitioner or a legitimate Canadian telehealth clinic. We only recommend providers that prescribe medications with a valid Health Canada authorization for the indication they're treating. That's why the provider directory focuses on GLP-1 telehealth — the regulatory and evidence picture is clearer.

What Flatland Health covers

For most Canadians looking into "peptide therapy" for weight or metabolic health, the honest, legal path is Health Canada–authorized GLP-1 / GIP medicines — which are peptides, and which are properly authorized and marketed in Canada.

  • Semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound): the full GLP-1 guide.
  • Other peptide drugs: treat as an educational / specialist topic. Verify current DPD status; do not assume historical authorizations equal easy commercial access today.
  • Gray-market / RUO vials: we do not cover, recommend, or link to them. See the RUO explainer.

Sources: Health Canada peptide advisory · Drug Product Database